MapLight Therapeutics Inc.
MPLT | NASDAQ
$10.90
-$0.02 (-0.18%)
At close: Sep 21, 2026, 4:00 PM ET
$11.20
+$0.30 (+2.75%)
After-hours:
Sep 21, 2026, 6:22 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 578K | 701K | 556K | 574K |
Gross Profit | -578K | -701K | -556K | -574K |
Operating Income | -169.08M | -82.95M | -57.28M | -31.25M |
Interest Income | 5.52M | 4.5M | 1.1M | 429K |
Pretax Income | -161.15M | -77.58M | -55.71M | -30.02M |
Net Income | -161.15M | -77.58M | -55.71M | -30.02M |
Selling & General & Admin | 30.73M | 14.42M | 7.61M | 4.1M |
Research & Development | 137.77M | 67.82M | 49.12M | 26.57M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 168.51M | 82.25M | 56.73M | 30.67M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 169.08M | 82.95M | 57.28M | 31.25M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 44.02M | 41.43M | 41.43M | 41.43M |
Shares Outstanding (Diluted) | 44.02M | 41.43M | 41.43M | 41.43M |
EPS (Basic) | -3.66 | -1.87 | -1.34 | -0.72 |
EPS (Diluted) | -3.66 | -1.87 | -1.34 | -0.72 |
EBITDA | -160.57M | -76.88M | -55.15M | -29.44M |
EBIT | -161.15M | -77.58M | -55.71M | -30.02M |
Depreciation & Amortization | 578K | 701K | 556K | 574K |
Add to Watchlist
Select watchlists to add or remove MPLT